Gastrointestinal symptoms of Henoch-Schönlein purpura treated with mycophenolate mofetil

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 2, 2006, Pages 245-247

  Martin, Scott ^a   Cramer, Carl H ^b   Heikenen, Janice ^a   Gitomer, Jeremy J ^c  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Children's Hospital at Providence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ABDOMINAL DISEASE; ABDOMINAL RADIOGRAPHY; ANAPHYLACTOID PURPURA; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; ENDOSCOPY; ESOPHAGOGASTRODUODENOSCOPY; FOOD INTAKE; GASTROINTESTINAL DISEASE; HEMATEMESIS; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PARENTERAL NUTRITION; PERFORATION; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; URINALYSIS;

ABDOMINAL PAIN; CHILD; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; PURPURA, SCHOENLEIN-HENOCH; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33746848618     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189369.45158.e3     Document Type: Article

References (33)

1. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990;33:1114-21.
2. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schönlein-Henoch syndrome): review with a follow-up of the renal complications. Am J Dis Child 1960;99:833-54.
3. Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in children with Henoch-Schönlein purpura. Pediatrics 1987;79:1018-21.
4. Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine 1999;78:395-409.
5. Saulsbury F. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schönlein purpura. Arthritis Rheum 1992;35:1377-80.
6. Rai A, Nast C, Adler S. Henoch-Schönlein purpura nephritis. J Am Soc Nephrol 1999;10:2637-44.
7. Kauffmann RH, Herrmann WA, Meyer CJ, et al. Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med 1980;69:859-66.
8. Saulsbury FT. Increased serum IgD concentrations in children with Henoch-Schönlein purpura. Br J Rheumatol 1998;37:570-2.
9. Stanbury RM, Graham EM. Systemic corticosteroid therapy: side effects and their management. Br J Ophthalmol 1998;82:704-8.
10. Wang IJ, Hsu WM, Shun CT, et al. Juvenile dermatomyositis complicated with vasculitis and duodenal perforation. J Formos Med Assoc 2001;100:844-6.
11. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001;33:289-94.
12. Hernandez-Diaz S, Rodriguez LA. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol 2001;153:1089-93.
13. Sakallioglu AE, Arda IS, Sevmis S, et al. A very rare consequence of steroid therapy: ileal perforation in a patient with familial Mediterranean fever. J Pediatr Surg 2004;39:1724-25.
14. O'Neil EA, Chwals WJ, O'Shea MD, et al. Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child 1992;67:10-1.
15. Gordon PV, Marshall DD, Stiles AD, et al. The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: from the baby's bowel to the researcher's bench. Mol Genet Metab 2001;72:91-103.
16. Gordon PV, Price WA, Stiles AD, et al. Early postnatal dexamethasone diminishes transforming growth factor alpha localization within the ileal muscularis propria of newborn mice and extremely low-birth-weight infants. Pediatr Dev Pathol 2001;4:532-7.
17. Lawes D, Wood J. Acute abdomen in Henoch-Schönlein purpura. J R Soc Med 2002;95:505-6.
18. Chang WL, Yang YH, Lin YT, et al. Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients. Acta Paediatr 2004;93:1427-31.
19. Yavuz H, Arslan A. Henoch-Schönlein purpura-related intestinal perforation: a steroid complication? Pediatr Int 2001;43:423-5.
20. Yigiter M, Bosnali O, Sekmenli T, et al. Multiple and recurrent intestinal perforations: an unusual complication of Henoch-Schönlein purpura. Eur J Pediatr Surg 2005;15:125-7.
21. Hyams JS. Corticosteroids in the treatment of gastrointestinal disease. Curr Opin Pediatr 2000;12:451-5.
22. van den Broek RW, van Rossum MA, van Duinen CM. A new surgical complication related to corticosteroids in a patient with Henoch-Schönlein purpura. J Pediatr Surg 1995;30:1341-3.
23. Huang DC, Yang YH, Lin YT, et al. Cyclosporin A therapy for steroid-dependent Henoch-Schönlein purpura. J Microbiol Immunol Infect 2003;36:61-4.
24. Bumgardner GL, Roberts JP. New immunosuppressive agents. Gastroenterol Clin North Am 1993;22:421-49.
25. Allison AC, Eugui EM. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc 1994;26:3205-10.
26. Groth CG, Ohlman S, Gannedahl G, Ericzon BG. New immunosuppressive drugs in transplantation. Transplant Proc 1993; 25:2681-3.
27. Allison AC, Eugui EM. Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs. Transplant Proc 1993;25:8-18.
28. Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation 1993;56:75-82.
29. Mamelok R. From mechanisms to long-term benefits. Transplantation 2005;79:S43-4.
30. Novak J. The role of endoscopy in the diagnosis of Schönlein-Henoch purpura. Orv Hetil 1997;138:2169-73.
31. Dooley MA, Cosio FG, Nachman PH, et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999;10:833-9.
32. Joy MS, Hogan SL, Jennette JC, et al. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant 2005;20:2725-32.
33. Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus 2005;14:S2-8.